ABBOTT LABORATORIES — Director's Dealing 2004

May 6, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-05-03

Reporting Person: REYNOLDS W ANN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-05-03	Stock equivalent units	$0	A	4132	Acquired		common shares (4132)	Direct

Footnotes

F1: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.